Медицинский совет (Dec 2016)

INDIVIDUAL APPROACH TO ULTRA LOSE DOSE REGIME OF MENOPAUSAL HORMONAL THERAPY IN PATIENTS AGED OVER 60

  • L. Y. Karakhalis,
  • G. A. Penzhoyan,
  • M. N. Mogilina,
  • E. V. Arutyunova

DOI
https://doi.org/10.21518/2079-701X-2016-12-106-110
Journal volume & issue
Vol. 0, no. 12
pp. 106 – 110

Abstract

Read online

The menopausal hormonal therapy is represented today by ultra low doses in the form of drug Angeliq® Micro, which allows continuing MHT for patients older than 60-65 and choosing an individual MHT type.

Keywords